Total contacts commenced screening | 247 (100) |
Gender | |
Male | 107 (43.3) |
Female | 140 (56.7) |
Age, years | |
<18 | 27 (10.9) |
18–24 | 16 (6.4) |
25–34 | 76 (30.8) |
35–44 | 43 (17.4) |
45–54 | 38 (15.4) |
55–64 | 29 (11.7) |
65+ | 18 (7.3) |
Country of birth | |
Africa | 12 (4.9) |
East Asia | 18 (7.3) |
South Asia | 26 (10.5) |
Southeast Asia | 65 (26.3) |
West Asia | 4 (1.6) |
Europe | 4 (1.6) |
South America | 1 (0.4) |
North America | 1 (0.4) |
Australia and New Zealand | 81 (32.8) |
Not documented | 35 (14.2) |
Employment status | |
Working full-time | 87 (35.2) |
Working part-time | 91 (36.8) |
Unemployed | 23 (9.3) |
Studying | 31 (12.6) |
Not stated | 15 (6.1) |
Smoking status | |
Lifelong non-smoker | 185 (74.9) |
Current smoker | 12 (4.9) |
Ex-smoker | 15 (6.1) |
Not documented | 35 (14.2) |
Alcohol usage | |
Does not drink | 159 (64.4) |
Social usage | 58 (23.5) |
Excessive usage | 8 (3.2) |
Not documented | 22 (30.9) |
IVDU | |
Non-IVDU | 222 (89.9) |
Current IVDU | 0 (0) |
Ex-IVDU | 3 (1.2) |
Not documented | 22 (30.9) |
Bacille Calmette–Guérin scar | |
Yes | 57 (23.1) |
No | 30 (12.1) |
Not documented | 160 (64.8) |
Medical comorbidities | |
HIV | |
Yes | 0 (0) |
No | 221 (89.5) |
Not documented | 26 (10.5) |
Diabetes mellitus | |
Yes | 30 (12.1) |
No | 209 (84.6) |
Not documented | 8 (3.2) |
Immunosuppression | |
Yes | 0 (0) |
No | 231 (93.5) |
Not documented | 16 (6.5) |
Types of contact | |
Household | 94 (38) |
Institutional/healthcare | 71 (28.7) |
Other | 10 (4) |
Not documented | 72 (29.1) |
Data presented as n (%). MDR: multidrug resistant; TB: tuberculosis; IVDU: intravenous drug user.